ESC 365 - Dapagliflozin reduced lactate release by epicardial adipose tissue from CAD patients: switch from fatty acids to glucose aerobic oxidation

ESC Premium Access

Dapagliflozin reduced lactate release by epicardial adipose tissue from CAD patients: switch from fatty acids to glucose aerobic oxidation

Session: Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

Topic: Drugs, Drug Targets

Speaker: Doctor M. Couselo Seijas (Madrid, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Marinela Couselo Seijas

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

0 follower

11 more presentations in this session

Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.

Speaker: Professor I. Andreadou (Athens, GR)

Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity

Speaker: Doctor S. Tual-Chalot (Newcastle-Upon-Tyne, GB)

Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction

Speaker: Doctor G. Vilahur (Barcelona, ES)

Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness

Speaker: Professor G. De Luca (Messina, IT)

Carvedilol and its analogue VK-II-86 attenuate stretch-induced manifestations of mechanoelectric feedback.

Speaker: Miss I. Del Canto Serrano (Valencia, ES)

Access the full session

Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

Speakers: Doctor M. Couselo Seijas, Professor I. Andreadou, Doctor S. Tual-Chalot, Doctor G. Vilahur, Professor G. De Luca...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources